Capillary Electrophoresis - Mass Spectrometry: Transforming Biotherapeutics Quality Assessment

Duration - 23 Minutes

Price - INR-400 / USD-8
Book Now   Enquire Now  

About the course

 New trends in Biopharma besides mAb viz. ADC, Fusion Proteins and BsAbs
 Charge heterogeneity is one of the key CQA need to be monitored
 The cIEF-MS is the most appropriate technology to address the charge heterogeneity application challenge
 The Agilent CE and MS coupled with EMASS-II CE-MS source provide seamless workflow for this application. This talk describes this approach and few examples

Speaker Profile

Dr. Ashish Pargaonkar

Manager, Center of Excellence, Bangalore – Mumbai
Agilent Technologies India

Website by: Xpoteck